A detailed history of Sage Private Wealth Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sage Private Wealth Group, LLC holds 1,543 shares of LLY stock, worth $1.36 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
1,543
Previous 1,638 5.8%
Holding current value
$1.36 Million
Previous $1.45 Million 17.92%
% of portfolio
0.89%
Previous 1.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$727.2 - $932.06 $69,084 - $88,545
-95 Reduced 5.8%
1,543 $1.19 Million
Q3 2024

Jan 29, 2025

SELL
$772.14 - $960.02 $25,480 - $31,680
-33 Reduced 1.97%
1,638 $1.45 Million
Q2 2024

Jan 29, 2025

SELL
$724.87 - $909.04 $42,767 - $53,633
-59 Reduced 3.41%
1,671 $1.51 Million
Q1 2024

Jan 29, 2025

BUY
$592.2 - $792.28 $11,251 - $15,053
19 Added 1.11%
1,730 $1.35 Million
Q4 2023

Jan 29, 2025

BUY
$525.19 - $619.13 $898,600 - $1.06 Million
1,711 New
1,711 $997,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $835B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sage Private Wealth Group, LLC Portfolio

Follow Sage Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Private Wealth Group, LLC with notifications on news.